Oligonucleotide Synthesis Markets: Forecasts by Application (Including COVID-19), End User and Product with Executive and Consultant Guides Including Customized Forecasting and Analysis 2020 to 2025
Synthetic Oligonucleotides are poised for explosive growth as gene technology moves into mainstream healthcare, food production and even data storage! We are not kidding. The market for small snippets of DNA, called Oligonucleotides, is growing into a market for Synthetic DNA where organisms, like algae, are 'custom designed' to produce food and medicine while consuming few resources. In applications like CRISPR Gene Editing and COVID-19 Synthetic Antibodies these 'Oligos' are already getting to work. The possibilities and market growth are unlimited.
Our analysis shows that investors do not yet understand the scope of this technology and the enormous market opportunity. Small biotechs are in a position to become huge multinationals, all based on producing DNA and its building blocks. Learn all about it and see our forecasts to 2025 in this comprehensive report.
This is a complex area and this report will bring the entire management team up to speed, on both the technology and the opportunity. The technology is moving fast - coming out of the lab and onto the desktop as genetics crosses the chasm into mainstream commerce.
All report data is available in Excel format on request with the corporate license.
Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Check all your licensing options, however your order is available as a credit if you wish to upgrade. We wrote this report and are ready by phone or email to help you use it.
Assistance and additional breakout data is available free of charge with the corporate license.
Subscribe and Save
By signing up for the annual subscription, updates to this report will be automatically provided free of charge for a period of one year from initial purchase. These updates can include revised forecasts as markets increase or contract and exclusive market commentary not seen anywhere else. With the effects of COVID-19 being felt across all markets it has never been more crucial to stay fully informed with real-world actionable data. Subscribe to this report and receive ongoing market forecasting and analysis for sharpened strategic planning throughout the year.
- Quarterly report updates
- Summary of significant developments and market changes
- Phone consultation and assistance on request for the duration of the subscription
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School